Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
OpthoPatch is a commercial pediatric eye-care brand operated by Defined Vision, a New York company focused on adhesive eye patches used in occlusion therapy. Its products are designed for children and infants with amblyopia, lazy eye, cross-eye/strabismus, and related post-operative eye conditions. The brand sells breathable, hypoallergenic eye patches with blackout protection, including standard extra-sensitive adhesive products and newer silicone-adhesive versions. OpthoPatch appears to be a product brand rather than a drug-development biotech company, with its activity centered on marketed ophthalmic treatment accessories sold direct-to-consumer and through retail marketplaces.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on OpthoPatch.